Biological behavior of CIN lesions is predictable by multiple parameter logistic regression models

Carcinogenesis

Volumn 29, Issue 4, 2008, Pages 840-845

  van hamont, D ^a   Bulten, J ^a   Shirango, H ^a   Melchers, W J G ^a   Massuger, L F A G ^a   de Wilde, P C M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN;

ADULT; ARTICLE; CANCER GROWTH; CANCER REGRESSION; CELL FRACTIONATION; CELL NUCLEUS; CELL PROLIFERATION; CHROMOSOME 1; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HUMAN TISSUE; LABELING INDEX; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PRECANCER; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX TUMOR; WART VIRUS;

CERVICAL INTRAEPITHELIAL NEOPLASIA; COHORT STUDIES; COLPOSCOPY; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MODELS, STATISTICAL; PAPILLOMAVIRIDAE; REGRESSION ANALYSIS; VAGINAL SMEARS;

EID: 41849088078     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgm287     Document Type: Article

References (39)

1. Richart,R.M. (1969) A theory of cervical carcinogenesis. Obstet. Gynecol. Surv., 24, 874-879.
2. Keijser,K.G. et al. (1992) Diathermy loop excision in the management of cervical intraepithelial neoplasia: Diagnosis and treatment in one procedure. Am. J. Obstet. Gynecol., 166, 1281-1287.
3. Prendiville, W. et al. (1989) Large loop excision of the transformation zone (LLETZ). A new method of management for women with cervical intra-epithelial neoplasia. Br. J. Obstet. Gynaecol., 96, 1054-1060.
4. van Hamont,D. et al. (2006) Long-term follow-up after large-loop excision of the transformation zone: Evaluation of 22 years treatment of high-grade cervical intraepithelial neoplasia. Int. J. Gynecol. Cancer, 16, 615-619.
5. Östor,A.G. (1993) Natural history of cervical intraepithelial neoplasia: A critical review. Int. J. Gynecol. Pathol., 12, 186-192.
6. McIndoe,W.A. et al. (1984) The invasive potential of carcinoma in situ of the cervix. Obstet. Gynecol., 64, 451-458.
7. zur Hausen,H. et al. (1984) Viruses in the etiology of human genital cancer. Prog. Med. Virol., 30, 170-186.
8. Walboomers,J.M. et al. (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol., 189 12-19.
9. Melchers,W.J. et al. (1999) Short fragment polymerase chain reaction reverse hybridization line probe assay to detect and genotype a broad spectrum of human papillomavirus types. Clinical evaluation and follow-up. Am. J. Pathol. 155, 1473-1478.
10. Munger,K. et al. (2004) Mechanisms of human papillomavirus-induced oncogenesis. J. Virol., 78, 11451-11460.
11. Thorland,E.C. et al. (2003) Common fragile sites are preferential targets for HPV16 integrations in cervical tumors. Oncogene, 22 1225-1237.
12. zur Hausen,H. (2002) Papillomaviruses and cancer: From basic studies to clinical application. Nat. Rev. Cancer, 2, 342-350.
13. Atkin,N.B. et al. (1990) Chromosome changes in 43 carcinomas of the cervix uteri. Cancer Genet. Cytogenet., 44, 229-241.
14. Sreekantaiah.C. et al. (1988) Chromosome 1 abnormalities in cervical carcinoma. Cancer, 62, 1317-1324.
15. Bulten,J. et al. (1998) Interphase cytogenetic analysis of cervical intraepithelial neoplasia. Am. J. Pathol., 152, 495-503.
16. Bulten,J. et al. (2002) Numerical aberrations of chromosome 1 in cervical intraepithelial neoplasia are strongly associated with infection with high-risk human papillomavirus types. J. Pathol., 198, 300-309.
17. Gerdes,J. et al. (1984) Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J. Immunol., 133, 1710-1715.
18. al-Saleh,W. et al. (1995).Assessment of Ki-67 antigen immunostaining in squamous intraepithelial lesions of the uterine cervix. Correlation with the histologic grade and human papillomavirus type. Am. J. Clin. Pathol., 104, 154-160.
19. Bulten,J. et al. (1996) MIB1, a promising marker for the classification of cervical intraepithelial neoplasia. J. Pathol., 178, 268-273.
20. Sahebali,S. et al. (2003) Ki-67 immunocytochemistry in liquid based cervical cytology: Useful as an adjunctive tool? J. Clin. Pathol., 56, 681-686.
21. Kerstens,H.M. et al. (2000) AgarCyto: A novel cell-processing method for multiple molecular diagnostic analyses of the uterine cervix. J. Histochem. Cytochem., 48, 709-718.
22. Kleter,B. et al. (1998) Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am. J. Pathol., 153, 1731-1739.
23. Perrons,C. et al. (2002) Detection and genotyping of human papillomavirus DNA by SPF10 and MY09/11 primers in cervical cells taken from women attending a colposcopy clinic. J. Med. Virol., 67 246-252.
24. Quint,W.G. et al. (2001) Comparative analysis of human papillomavirus infections in cervical scrapes and biopsy specimens by general SPF(10) PCR and HPV genotyping. J. Pathol., 194, 51-58.
25. Kerstens,H.M. et al. (1995) A novel in situ hybridization signal amplification method based on the deposition of biotinylated tyramine. J. Histochem. Cytochem., 43, 347-352.
26. Harrell,F.E. (2001) Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis. Springer-Verlag New York Inc.
27. Hosmer,D.W. et al. Applied Logistic Regression. 2nd edn. New York, NY: John Wiley & Sons, Inc.; (2007).
28. Arbyn,M. et al. (2004) Virologic versus cytologic triage of women with equivocal Pap smears: A meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia. J. Natl Cancer Inst., 96 280-293.
29. Snijders,P.J. et al. (2003) The clinical relevance of human papillomavirus testing: Relationship between analytical and clinical sensitivity. J. Pathol., 201, 1-6.
30. Segers,P. et al. (1994) Detection of premalignant stages in cervical smears with a biotinylated probe for chromosome 1. Cancer Genet, Cytogenet., 75, 120-129.
31. Southern,S.A. et al. (1997) Basal cell tetrasomy in low-grade cervical squamous intraepithelial lesions infected with high-risk human papilloma-viruses. Cancer Res., 57, 4210-4213.
32. McCluggage,W.G. et al. (1996) Monoclonal antibody MIB1 in the assessment of cervical squamous intraepithelial lesions. Int. J. Gynecol. Pathol., 15, 131-136.
33. Pahlplatz,M.M. et al. (1995) A model for evaluation of in situ hybridization spot-count distributions in tissue sections. Cytometry, 20, 193-202.
34. Sahebali,S. et al. (2006) Immunocytochemistry in liquid-based cervical cytology: Analysis of clinical use following a cross-sectional study. Int. J. Cancer, 118, 1254-1260.
35. Wright, T.C.Jr. et al.. (2002) Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA, 287, 2120-2129.
36. Cuzick,J. et al. (2003) Management of women who test positive for high-risk types of human papillomavirus: The HART study. Lancet, 362, 1871-1876.
37. Ho,L. et al. (2003) Human papillomavirus DNA detection in the management of women with twice mildly abnormal cytological smears. J. Med. Virol., 69, 118-121.
38. Zielinski,G.D. et al. (2001) HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears. Br. J. Cancer, 85, 398-404.
39. Bais,A.G. et al. (2005) Triage using HPV-testing in persistent borderline and mildly dyskaryotic smears: Proposal for new guidelines. Int. J. Cancer, 116, 122-129.